Cargando…

Therapeutic vaccines for high-risk HPV-associated diseases

Cancer is the second leading cause of death worldwide, and it is estimated that Human papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV vaccines are extremely effective at preventing infection and neoplastic disease; however, they are prophylactic and do not clear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chabeda, Aleyo, Yanez, Romana J.R., Lamprecht, Renate, Meyers, Ann E., Rybicki, Edward P., Hitzeroth, Inga I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887015/ https://www.ncbi.nlm.nih.gov/pubmed/29277575 http://dx.doi.org/10.1016/j.pvr.2017.12.006

Ejemplares similares

Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
por: Chabeda, Aleyo, et al.
Publicado: (2019)

LALF(32‐51)‐E7, a HPV‐16 therapeutic vaccine candidate, forms protein body‐like structures when expressed in Nicotiana benthamiana leaves
por: Yanez, Romana J. R., et al.
Publicado: (2017)

Optimizing a Human Papillomavirus Type 16 L1-Based Chimaeric Gene for Expression in Plants
por: Hitzeroth, Inga I., et al.
Publicado: (2018)

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana
por: Yanez, Romana J. R., et al.
Publicado: (2017)

A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice
por: Stander, Jennifer, et al.
Publicado: (2021)

African Horse Sickness: A Review of Current Understanding and Vaccine Development
por: Dennis, Susan J, et al.
Publicado: (2019)

Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice
por: Whitehead, Mark, et al.
Publicado: (2014)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum
por: Kohl, Thomas O, et al.
Publicado: (2007)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016)

Transient Expression and Purification of Horseradish Peroxidase C in Nicotiana benthamiana
por: Huddy, Suzanne M., et al.
Publicado: (2018)

Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana
por: Regnard, Guy L., et al.
Publicado: (2017)

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
por: Pietersen, Inge, et al.
Publicado: (2020)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Setting up a platform for plant-based influenza virus vaccine production in South Africa
por: Mortimer, Elizabeth, et al.
Publicado: (2012)

Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
por: Gunter, Cornelius J., et al.
Publicado: (2019)

Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya
por: Masika, Moses Muia, et al.
Publicado: (2015)

Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine
por: Mbewana, Sandiswa, et al.
Publicado: (2015)

Complete Genome Sequences of Two Isolates of Canis familiaris Oral Papillomavirus from South Africa
por: Regnard, Guy L., et al.
Publicado: (2016)

Complete Genome Sequence of Bos taurus Papillomavirus Type 1, Isolated in Morocco
por: Regnard, Guy L., et al.
Publicado: (2017)

Transient protein expression in tobacco BY-2 plant cell packs using single and multi-cassette replicating vectors
por: Poborilova, Zuzana, et al.
Publicado: (2020)

Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana
por: Pêra, Francisco F. P. G., et al.
Publicado: (2015)

Development of plant-produced protein body vaccine candidates for bluetongue virus
por: van Zyl, Albertha R., et al.
Publicado: (2017)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Perspectives for therapeutic HPV vaccine development
por: Yang, Andrew, et al.
Publicado: (2016)

Therapeutic Vaccines for HPV-Associated Malignancies
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Therapeutic Vaccination for HPV-Mediated Cancers
por: Yan, Flora, et al.
Publicado: (2023)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study
por: Moodley, Jennifer R, et al.
Publicado: (2009)

A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding
por: Margolin, Emmanuel, et al.
Publicado: (2020)

Production of complex viral glycoproteins in plants as vaccine immunogens
por: Margolin, Emmanuel, et al.
Publicado: (2018)

Differential Dependence on Host Cell Glycosaminoglycans for Infection of Epithelial Cells by High-Risk HPV Types
por: Cruz, Linda, et al.
Publicado: (2013)

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
por: Bowden, Sarah J., et al.
Publicado: (2022)

Extended Set of GoldenBraid Compatible Vectors for Fast Assembly of Multigenic Constructs and Their Use to Create Geminiviral Expression Vectors
por: Dusek, Jakub, et al.
Publicado: (2020)

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
por: Hooi, Desiree J, et al.
Publicado: (2018)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1329hfge8323id8bb3pnrhj8d6